Richard Payne, MD is the Esther Colliflower Professor of Medicine and Divinity at Duke University, and holder of the John B. Francis Chair in Bioethics at the Center for Practical Bioethics, Kansas City, Missouri. Dr. Payne is an internationally known expert in the areas of pain relief, palliative care, oncology and neurology.
He is a graduate of Yale College, with a BA degree in Molecular Biophysics and Biochemistry (1973), and a M.D. degree from Harvard Medical School (1977). He did his postgraduate medical training in internal medicine at the Peter Bent Brigham Hospital in Boston and in neurology at the New York Hospital-Cornell Medical Center in New York. Dr. Payne did post residency research fellowship training in neuro-oncology, pharmacology and pain management at Cornell U. Medical College and Memorial Sloan-Kettering Cancer Center in New York.
Prior to his appointment at Duke in 2004, Dr. Payne was Assistant Attending Physician at Memorial Sloan Kettering (1984-1987); Chief of the Dept. Neurology, Cincinnati VA Hospital and Vice-Chair, Dept. Neurology at the U. Cincinnati Medical Center (1987-1992), and Chief, Pain and Symptom Management Section, Dept. Neurology, at M.D. Anderson Cancer Center in Houston, TX (1992-1998). He returned to New York from 1998-2004 as Chief, Pain and Palliative Care Service at Memorial Sloan Kettering Cancer Center, and Anne Burnett Tandy Chair in Neurology as well as Professor of Neurology and Pharmacology at S. Weill Medical College at Cornell University.
Dr. Payne has served on numerous federal panels, including the Agency for Health Care Policy and Research, the NIH and the Institute of Medicine. He has given testimony before Congressional committees and has appeared on numerous national media. He is a past president of the American Pain Society (2003). He has published more than 275 papers and abstracts in the areas of pain research and management, palliative medicine and ethics. He has served or is serving on scientific and medical advisory boards of many pharmaceutical companies including, Merck, Pfizer, Eli Lilly, Janssen, Purdue Pharma, Endo, Johnson and Johnson, QRx Pharma, Relmada Pharmaceuticals, and Prolong Pharmaceuticals. Dr. Payne was a member of the Institute of Medicine Committee that released the recent report, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. He has co-edited four books: Current Therapy of Pain; Assessment and Treatment of Cancer Pain; Chronic Pain: An Atlas of Investigation and Management; and, Living Well and Dying Faithfully: Christian Practices for End-of-Life Care.
Dr. Payne has received numerous research awards and funding, including research grants from the NIH, and the Robert Wood Johnson Foundation, among others. Dr. Payne has served on the board of directors of The National Hospice and Palliative Care Association (palliative care representative), and The Foundation for Hospices in Sub-Saharan Africa (past board chair). He is past board chair of the National Coalition of Cancer Survivorship, and currently serves on the board of directors of the Hastings (Bioethics) Center.